{"id":"W2579967746","doi":"10.1182/blood.v112.11.2375.2375","title":"Economic Analysis of Alemtuzumab in Fludarabine-Refractory and Relapsed Chronic Lymphocytic Leukemia in Canada","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Fludarabine; Alemtuzumab; Medicine; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Population; Cyclophosphamide; Oncology; Surgery; Leukemia; Transplantation; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002315449,0.0001921852,0.0008118257,0.0007449512,0.00002871269,0.000004279134,0.0001549066,0.0001148345,0.0001739432],"category_scores_gemma":[0.0001086578,0.0001912006,0.00009469772,0.0008049512,0.0001530071,0.00007602225,0.00008153679,0.0002382241,0.000009083529],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2583994,"about_ca_system_score_gemma":0.2164616,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9600099,"about_ca_topic_score_gemma":0.9600499,"domain_scores_codex":[0.9980455,0.00006536268,0.0006377673,0.0004262159,0.000343629,0.0004815325],"domain_scores_gemma":[0.99889,0.0002450156,0.0001171557,0.0005274449,0.00003474196,0.0001856221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001648567,0.0006327555,0.8750395,0.00155399,0.005333714,0.01248821,0.002546286,0.0837788,0.01128188,0.0001330736,0.001343434,0.004219837],"study_design_scores_gemma":[0.1184743,0.0003843183,0.5826836,0.000273741,0.001190234,0.0007102977,0.0002348408,0.285742,0.009410425,0.00001314273,0.0004275504,0.0004555564],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962603,0.00245924,8.591933e-7,0.00002445251,0.00004322683,0.0002888651,0.00002054157,0.00001227272,0.0008901993],"genre_scores_gemma":[0.9984762,0.001071243,0.00004378195,0.00004954606,0.00004422801,0.00002388881,0.00003324446,0.000024973,0.0002329077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2923558,"threshold_uncertainty_score":0.7879804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01112387865916712,"score_gpt":0.239181564093093,"score_spread":0.2280576854339259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}